FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 305:185-190 July 23, 1981 Number 4 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We compared the initial and long-term effects of the beta-adrenergic agonist pirbuterol in 12 patients with chronic congestive heart failure. The drug's initial effect was a 35 per cent increase in cardiac index, but there was no significant change in heart rate or mean arterial pressure. After one month of therapy, the mean cardiac index and ejection fraction had returned to base-line values, and no clinical effect was evident in most patients. This apparent tolerance was not accompanied by changes in heart rate, blood pressure, or body weight, and it occurred in the presence of therapeutic drug levels during long-term therapy. The density of beta-adrenergic receptors on lymphocytes from patients treated with pirbuterol was significantly depressed as compared with that of patients with heart failure of comparable severity but not treated with pirbuterol. We conclude that tolerance to the hemodynamic and clinical effects of pirbuterol develops during long-term administration; this tolerance may be related to a decrease in myocardial or vascular beta-adrenergic receptors or both.

This article has been cited by other articles:

• York, K. M., Hassan, M., Li, Q., Li, H., Fillingim, R. B., Sheps, D. S. (2007). Coronary Artery Disease and Depression: Patients With More Depressive Symptoms Have Lower Cardiovascular Reactivity During Laboratory-Induced Mental Stress. Psychosom. Med. 69: 521-528 [Abstract] [Full Text]  
• Minneci, P. C., Deans, K. J., Banks, S. M., Costello, R., Csako, G., Eichacker, P. Q., Danner, R. L., Natanson, C., Solomon, S. B. (2004). Differing effects of epinephrine, norepinephrine, and vasopressin on survival in a canine model of septic shock. Am. J. Physiol. Heart Circ. Physiol. 287: H2545-H2554 [Abstract] [Full Text]  
• Akosah, K. O., Denlinger, B., Mohanty, P. K. (1999). Safety Profile and Hemodynamic Responses to {beta}-Adrenergic Stimulation by Dobutamine in Heart Transplant Patients*. Chest 116: 1587-1592 [Abstract] [Full Text]  
• Malmsjo, M., Bergdahl, A., Moller, S., Zhao, X.-H., Sun, X.-Y., Hedner, T., Edvinsson, L., Erlinge, D. (1999). Congestive heart failure induces downregulation of P2X1-receptors in resistance arteries. Cardiovasc Res 43: 219-227 [Abstract] [Full Text]  
• Guazzi, M. D., Agostoni, P. G., Doria, E., Loaldi, A., Pepi, M., Polese, A. (1985). Hemodynamic Response to Oral Prenalterol in Dilated Decompensated Cardiomyopathy as a Result of Cardiac and Vascular Effects. ANGIOLOGY 36: 857-866 [Abstract]  
• White, D. C., Hata, J. A., Shah, A. S., Glower, D. D., Lefkowitz, R. J., Koch, W. J. (2000). Preservation of myocardial beta -adrenergic receptor signaling delays the development of heart failure after myocardial infarction. Proc. Natl. Acad. Sci. USA 97: 5428-5433 [Abstract] [Full Text]